2 Biotech Stocks You Can Buy and Hold for the Next Decade

Biotech companies use living organisms to develop their therapies, and much like some living things, biotech stocks can be notoriously volatile. Part of that is due to the complexities of making biotech therapies.

The success rate for biotech start-ups is low, but Gilead Sciences (NASDAQ: GILD), founded 36 years ago and Regeneron Pharmaceuticals (NASDAQ: REGN), founded 35 years ago, have already stood the test of time. Over the past decade, each of the stocks has seen triple-digit percentage increases in total price, annual revenue, and earnings per share. More growth is likely ahead for both, and the strong potential in their pipelines makes them great long-term holds for the next decade. Both companies also trade for less than 21 times earnings, making them well-priced compared to many biotech stocks.

GILD Total Return Level data by YCharts.